oxaliplatino EP/USP Pharmaceutical API Drug treatment of colorectal cancer made in china
6 Inquiries
61825-94-3
2026-07-21
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywords
oxaliplatino
oxaliplatino API
oxaliplatin
Quick DetailsProName:oxaliplatino EP/USP Pharmaceutical API Drug treatment of colorectal cancer made in china
CasNo:61825-94-3
Molecular Formula:C8H14N2O4Pt
Appearance:white crystalline powder
Application:used in medicine
DeliveryTime:prompt shipment
PackAge:as required
Port:China main port
ProductionCapacity:Metric Ton/Day
Purity:≥99.0%
Storage:Room temperature
Transportation:by sea by air express
LimitNum:100 Gram
Superiority
99%min we have GMP
DetailsOxaliplatin
Appearance
White or almost white crystalline powder.
Solubility
slightly soluble in water, very slightly soluble in
methanol, practically insoluble in ethanol.
Identification
A. Infrared absorption spectrum
B. It complies with the test for specific optical rotation (see Tests).
Appearance of solution
The solution is clear and colourless.
Acidity
The solution is colorless, and NMT 0.6ml of 0.01M sodium hydroxide is required to change the color to pink.
Specific optical rotation
+74.5°～+78.0°
Content of Platinum
48.1%～50.1% of the Oxaliplatin taken, on the dried basis
Related substances
Impurity A≤0.1%
Impurity B≤0.1%
Impurity C≤0.1%
Any other impurity ≤0.1%
Total of other impurities ≤0.1%
Total impurities(the sum of impurities A, B, C and
other related impurities) ≤0.30%
Impurity D≤0.1%
Silver
≤5.0ppm
Loss on drying
≤0.5%
Bacterial endotoxins Test
≤1.0IU/mg of Oxaliplatin
Assay
98.0 per cent to 102.0 per cent (dried substance).
Microbial Enumeration Tests and Tests and for Specified Microorganisms
Total aerobic microbial count ≤20CFU/g
Total combined molds and yeast count≤5CFU/g
Basic Info-
Product Name:
Oxaliplatin
Other Name:Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;Platinum,(1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-,[SP-4-2-(1R-trans)]-;Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;1,2-Cyclohexanediamine,platinum complex,(1R-trans)-;(SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum;NSC 266046;Oxalatoplatinum;Oxalatoplatin;l-OHP;Oxaliplatin;RP 54780;Platinum,(1,2-cyclohexanediamine-κN,κN′)[ethanedioato(2-)-κO1,κO2]-,[SP-4-2-(1R-trans)]-;Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II);Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II);Eloxatin;Dacplat;trans-L-Diaminocyclohexane oxalatoplatinum;Elplat;Lipoxal
CAS No.:61825-94-3
Molecular Formula:C8H14N2O4Pt
InChIKeys:InChIKey=ZROHGHOFXNOHSO-BNTLRKBRSA-L
Molecular Weight:397.28600
Exact Mass:397.06000
HScode:28439000
Categories:
Characteristics-
PSA:
104.64000
XLogP3:0.61450
Boiling Point:193.6ºC at 760 mmHg
Flash Point:75ºC
Water Solubility:Slightly soluble in water, very slightly soluble in methanol, practically insoluble in anhydrous ethanol. | soluble in water with heating and/or sonication
Toxicity:LD50 intraperitoneal in mouse: 19800ug/kg
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Skin sensitization, Category 1
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
Carcinogenicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H317 May cause an allergic skin reaction
H319 Causes serious eye irritation
H335 May cause respiratory irritation
H351 Suspected of causing cancer
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P272 Contaminated work clothing should not be allowed out of the workplace.
P271 Use only outdoors or in a well-ventilated area.
P203 Obtain, read and follow all safety instructions before use.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P333+P317 If skin irritation or rash occurs: Get medical help.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
P318 IF exposed or concerned, get medical advice.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted 
India
oxaliplatin
5 KG Nov 20, 2025
India
oxaliplatin
1 KG Jan 9, 2026 
Japan
Oxaliplatin(GMP+CEP)
100 G May 10, 2024
India
Oxaliplatin
500 G Feb 27, 2026 
Bangladesh
Oxaliplatin
25 KG Sep 23, 2025
Bangladesh
Butyl Acetate
1.00 KG Nov 11, 2025 Post an enquiry for this product
